Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 4,053 shares at $195.00 ($808K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($808k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.00 | 61 | $12K | 1.5% |
| 2 | $199.30 | 3,992 | $796K | 98.5% |
| Total | $199.24 avg | 4,053 | $808K | 100% |
| Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |
| RVMD | SELL | 2025-12-18 | $479K | — | Filing → |